We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLDO
3001
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
-19,356
Closed -$144K
STXB
3002
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
-194,636
Closed -$4.45M
ESXB
3003
DELISTED
Community Bankers Trust Corporation
ESXB
-355,800
Closed -$4.04M
RAVN
3004
DELISTED
Raven Industries Inc
RAVN
-111,048
Closed -$6.42M
CNBKA
3005
DELISTED
Century Bancorp Inc/Mass
CNBKA
-3,678
Closed -$419K
SNR
3006
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
-51,227
Closed -$450K
PFBI
3007
DELISTED
Premier Financial Bancorp
PFBI
-11,464
Closed -$193K
TBIO
3008
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-911,191
Closed -$25.1M
CMIIU
3009
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
-1,658,794
Closed -$22.3M
CORE
3010
DELISTED
Core Mark Holding Co., Inc.
CORE
-37,721
Closed -$1.7M
SHSP
3011
DELISTED
SharpSpring, Inc.
SHSP
-10,400
Closed -$176K
PFPT
3012
DELISTED
Proofpoint, Inc.
PFPT
-260,905
Closed -$45.3M
QTS
3013
DELISTED
QTS REALTY TRUST, INC.
QTS
-20,664
Closed -$1.6M
CEREW
3014
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
-223,127
Closed -$3.18M
SYKE
3015
DELISTED
SYKES Enterprises Inc
SYKE
-23,415
Closed -$1.26M
MXIM
3016
DELISTED
Maxim Integrated Products
MXIM
-3,735,433
Closed -$394M
USCR
3017
DELISTED
U S Concrete, Inc.
USCR
-11,621
Closed -$858K
WRI
3018
DELISTED
Weingarten Realty Investors
WRI
-88,743
Closed -$2.85M
SWI
3019
DELISTED
SolarWinds Corporation Common Stock
SWI
-11,763
Closed -$210K
HOME
3020
DELISTED
At Home Group Inc.
HOME
-23,362
Closed -$861K
CMLFU
3021
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
-2,090,987
Closed -$34.2M
ALSK
3022
DELISTED
Alaska Communications Systems
ALSK
-64,600
Closed -$215K
ALXN
3023
DELISTED
Alexion Pharmaceuticals
ALXN
-725,032
Closed -$133M
WORK
3024
DELISTED
Slack Technologies, Inc.
WORK
-1,633,036
Closed -$72.3M
CNST
3025
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
-17,840
Closed -$603K

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.